Amp Capital Investors LTD Novo Cure LTD Transaction History

Amp Capital Investors LTD

  • $0
  • Q4 2022

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 14, 2022
SELL
$75.08 - $121.99 $1.5 Million - $2.43 Million
-19,933 Closed
0 $0
Q3 2021

Nov 15, 2021
SELL
$116.17 - $194.55 $75,626 - $126,652
-651 Reduced 3.16%
19,933 $2.32 Million
Q2 2021

Aug 16, 2021
BUY
$130.4 - $225.58 $438,926 - $759,302
3,366 Added 19.55%
20,584 $4.57 Million
Q1 2021

May 17, 2021
BUY
$124.11 - $190.17 $1.03 Million - $1.59 Million
8,336 Added 93.85%
17,218 $2.27 Million
Q4 2020

Feb 12, 2021
BUY
$112.16 - $174.14 $996,205 - $1.55 Million
8,882 New
8,882 $1.55 Million

Others Institutions Holding NVCR

# of Institutions
263
Shares Held
77M
Call Options Held
1.17M
Put Options Held
318K
View Full List

About NovoCure Ltd

NVCR Quotes by TradingView
  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $1.97B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Amp Capital Investors LTD Portfolio

Follow Amp Capital Investors LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Amp Capital Investors LTD, based on Form 13F filings with the SEC.

News

Stay updated on Amp Capital Investors LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email